Soleil Research™

Microscopy image of a spinal cord motor neuron in a stained tissue smear at 400× magnification. Illustrative image, not a specimen from the ALS blood biomarker study.
ALS Blood Test Research: What a 10-Protein Panel Really Shows
A 2026 Nature Communications study identified a ten-protein plasma signature that distinguished known ALS cases from healthy controls with high accuracy. The findings are promising, but the panel needs validation... Read more...
Soleil Research illustration showing red blood cells, RHD and RHCE genes, Rh antigen expression, serologic interpretation, genotyping, and compatible transfusion planning.
Rh Diversity Beyond D: Why Genotyping Matters in Transfusion Medicine
A 2026 Transfusion study of 191 Kenyan blood donors shows how RHD and RHCE genotyping can reveal partial, weak, and complex Rh variants that routine RhD serology alone may not... Read more...
Conceptual illustration of red blood cells, RH and MNS genes, long-read sequencing, antigen expression, laboratory interpretation, and transfusion matching.
Blood Group Genomics: How Nanopore Sequencing Resolves Complex RH and MNS Variants
A Blood Advances proof-of-principle study shows how nanopore adaptive sampling can resolve complex RH and MNS blood-group variants that routine serology or standard molecular testing may not fully explain. Read more...
Colorized scanning electron micrograph of a human B lymphocyte, used illustratively for B-cell acute lymphoblastic leukemia coverage; not a trial participant or study specimen.
Blinatumomab in High-Risk Pediatric B-ALL: What AIEOP-BFM ALL 2017 Found
A large randomized phase 3 trial found improved event-free survival and fewer treatment-related infections when blinatumomab replaced two chemotherapy cycles in children with newly diagnosed high-risk B-cell ALL, while neurotoxicity... Read more...
Colorized electron micrograph of three Epstein-Barr virus particles, used as the featured image for a Soleil Research article on EBV-linked immune changes preceding multiple sclerosis relapse. Image credit: NIAID.
EBV Reactivation Before Multiple Sclerosis Relapse: What a New Nature Medicine Study Found
A new Nature Medicine study finds EBV-linked B-cell and monocyte changes in blood before some multiple sclerosis relapses. Multiple assays support the temporal association, but the observational design does not... Read more...
Figure 5 from Barron et al., Nature Medicine (2026), showing that levetiracetam reduces GABAergic neuron-to-glioma synaptic currents in diffuse midline glioma experimental models.
Levetiracetam in Diffuse Midline Glioma: What the New Nature Medicine Study Found
A new Nature Medicine study links levetiracetam exposure with longer survival in children with diffuse midline glioma and provides preclinical evidence that the drug may attenuate tumor-promoting GABAergic neuron-to-glioma synaptic... Read more...
Microscopic view of smoldering myeloma cells, shown in purple, among surrounding blood cells; featured for Soleil Research coverage of the ImmunoPRISM teclistamab phase 2 trial.
Teclistamab in High-Risk Smoldering Multiple Myeloma: What ImmunoPRISM Found
A randomized phase 2 trial found substantially deeper responses and a strong progression-free survival signal with teclistamab versus lenalidomide-dexamethasone in high-risk smoldering multiple myeloma, while important questions about long-term benefit,... Read more...
Chemical structure of oveporexton, an oral orexin receptor 2-selective agonist studied in the First Light and Radiant Light phase 3 narcolepsy type 1 trials.
Oveporexton in Narcolepsy Type 1: What Two Phase 3 Trials Found
Two phase 3 trials found that oveporexton substantially improved objective wakefulness, daytime sleepiness, and cataplexy over 12 weeks in narcolepsy type 1. Adverse events were common, particularly increased urinary frequency... Read more...
NIH illustration showing an embolic clot blocking a cerebral artery and causing ischemic stroke; illustrative image, not a LAIS trial participant or scan.
Loberamisal After Acute Ischemic Stroke: What the LAIS Trial Found
In the phase 3 LAIS trial, intravenous loberamisal improved the proportion of adults with acute ischemic stroke who reached an mRS score of 0–1 at 90 days. The result is... Read more...
Histopathology of poorly differentiated lung adenocarcinoma; illustrative image, not a TOP trial participant or specimen and not specific to EGFR/TP53-mutant NSCLC.
Osimertinib Plus Chemotherapy in EGFR/TP53-Mutant NSCLC: What the TOP Trial Found
The phase 3 TOP trial found that adding carboplatin-pemetrexed chemotherapy to first-line osimertinib substantially prolonged progression-free survival in selected patients with advanced EGFR/TP53-mutant NSCLC, but severe treatment-related toxicity increased markedly... Read more...
Bone marrow smear showing acute myeloid leukemia cells; illustrative microscopy image, not a PARADIGM trial participant or study specimen.
Azacitidine–Venetoclax vs Induction Chemotherapy in Fit AML: What PARADIGM Found
PARADIGM randomized 172 induction-eligible adults with newly diagnosed AML to azacitidine–venetoclax or induction chemotherapy. Event-free survival was longer with azacitidine–venetoclax, with fewer severe infections and hemorrhages, but the phase 2... Read more...
Illustration of the heart with normal sinus rhythm and atrial fibrillation ECG waveforms; educational image, not an IDEAL-AF trial participant or procedure image.
Low-Voltage Zone Ablation in Persistent Atrial Fibrillation: What the IDEAL-AF Trial Found
IDEAL-AF randomized 209 patients with persistent atrial fibrillation and significant low-voltage zones to PVI plus individualized LVZ ablation or PVI alone. Arrhythmia-free survival at 12 months was 67.6% vs 37.4%,... Read more...
National Cancer Institute medical illustration of the colon and rectum with surrounding digestive organs and nearby lymph nodes; illustrative image, not a SOLARIS trial participant or study specimen.
High-Dose Vitamin D in Metastatic Colorectal Cancer: What the SOLARIS Trial Found
The phase 3 SOLARIS trial randomized 455 adults with previously untreated metastatic colorectal cancer to high-dose or standard-dose vitamin D3 alongside chemotherapy plus bevacizumab. High-dose vitamin D3 did not significantly... Read more...
High-magnification H&E micrograph showing cardiac amyloid deposition; illustrative pathology image, not a CARDIO-TTRansform study specimen.
Eplontersen in Transthyretin Amyloid Cardiomyopathy: What CARDIO-TTRansform Found
In 1,432 adults with transthyretin amyloid cardiomyopathy, eplontersen every four weeks on top of standard care did not significantly reduce cardiovascular death plus recurrent cardiovascular clinical events over 140 weeks.... Read more...
Nurse caring for a newborn at Nkhoma Mission Hospital in Malawi; illustrative image, not an ALERT trial participant.
Improving Intrapartum Care in Sub-Saharan Africa: What the ALERT Trial Found
The ALERT stepped-wedge cluster-randomized trial evaluated a multi-faceted intrapartum-care intervention across 16 hospitals and 134,630 women in Benin, Malawi, Tanzania, and Uganda. Early perinatal mortality improved, while fresh stillbirth alone... Read more...
Medtronic Guardian Sensor 3 glucose sensor and Guardian Link 3 transmitter attached to skin, illustrating the CGM system used in the SIGNAL trial.
Continuous Glucose Monitoring Alerts in the Hospital: What the SIGNAL Trial Found
In the SIGNAL randomized trial of 533 hospitalized adults with diabetes, simple CGM threshold alerts modestly increased time in range compared with real-time CGM with alerts off. Adding predictive alerts... Read more...
Physician using a computer-based clinical information system, illustrating the clinical decision-support context of the SHAKED emergency-department study.
AI Decision Support in the Emergency Department: What the SHAKED Study Found
A prospective Nature Medicine evaluation of SHAKED followed 1,138 emergency-department patients. Sampled outputs were usually judged appropriate, but clinician adoption fell from 68% to 30%, highlighting the gap between technical... Read more...
Illustration of induced pluripotent stem cells, representing the cell source used to derive cardiomyocytes studied in the HEAL-CHF trial for advanced ischemic heart failure.
Stem Cell-Derived Cardiomyocytes in Advanced Heart Failure: What the HEAL-CHF Trial Found
HEAL-CHF tested hiPSC-derived cardiomyocytes during CABG in 20 patients. Some functional signals improved, but early ventricular arrhythmias raise caution. Read more...
NIH BioArt illustration of a blood platelet with surface projections
Cold-Stored Platelets Up to 21 Days: What the CHIPS Trial Found
The phase 3 CHIPS randomized trial found that cold-stored platelets kept for up to 21 days met prespecified noninferiority criteria for hemostatic efficacy versus standard room-temperature platelets in active bleeding... Read more...
Hospital patient receiving supplemental oxygen via nasal cannula with pulse oximeter monitoring and automated oxygen titration device — illustrating the SAVE-O₂ AI randomized clinical trial on autonomous oxygen management in acutely ill adults.
Autonomous Oxygen Titration in Acutely Ill Adults: What the SAVE-O₂ AI Trial Actually Demonstrated
The SAVE-O₂ AI randomized trial found that closed-loop oxygen titration substantially improved time within a target normoxemia range in acutely ill hospitalized adults. The study did not establish reductions in... Read more...
Overview of the PRISM2 multimodal pathology foundation model and clinical dialogue prediction tasks from Vorontsov et al., Nature Medicine 2026, used under CC BY 4.0.
PRISM2 in Digital Pathology: Can Clinical Dialogue Improve Whole-Slide Cancer Detection?
Soleil Research critically reviews PRISM2, a Nature Medicine multimodal pathology foundation model trained on more than 2.3 million whole-slide images and clinical dialogue, examining its cancer-detection performance, methodological strengths, reproducibility... Read more...
Scientific illustration for Soleil Research review of high-accuracy sequencing and detection of rare low-frequency genetic variants.
Detecting Rare Genetic Variants: How High-Accuracy Sequencing Pushes Beyond NGS Error Limits
Soleil Research reviews high-accuracy sequencing strategies for detecting low-frequency genetic variants, including single-strand and duplex consensus methods and the analytical challenge of distinguishing true molecular signals from NGS errors. Read more...
Scientific illustration for Soleil Research review of ensartinib in resected ALK-positive non-small-cell lung cancer.
Precision Medicine in Action: Ensartinib Reduces Disease Recurrence in Resected ALK-Positive Non–Small-Cell Lung Cancer
🔬 Soleil Research | High Impact ResearchFriday Edition — August 8, 2026📚 Original ReferenceZhou C, et al. Ensartinib in Resected ALK-Positive Non–Small-Cell Lung Cancer. The New England Journal of Medicine.... Read more...
Scientific illustration for Soleil Research review of cardiac myosin binding protein C, cMyC, as a cardiovascular biomarker.
A New Cardiac Biomarker Beyond Troponin: Cardiac Myosin Binding Protein C Shows Prognostic Value in the General Population
💪 Soleil Research | Laboratory MedicineWednesday Edition — August 6, 2026📚 Original ReferenceRøsjø H, et al. Prognostic Value of Cardiac Myosin Binding Protein C in the General Population: The Akershus... Read more...
Scientific illustration for Soleil Research review of MASLD biomarkers, liver biopsy alternatives, blood testing, and imaging.
Can Blood Tests and Imaging Reduce the Need for Liver Biopsy in MASLD?
A critical Soleil Research review of the 2026 LITMUS Imaging Study in Nature Medicine, examining NIS2+, magnetic resonance elastography, VCTE and Agile scores as non-invasive tools for MASH and fibrosis... Read more...